Treatment Set TS331955 is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Antigen Laboratories, Inc.. The primary component is Poa Pratensis Pollen; Cynodon Dactylon Pollen; Sorghum Halepense Pollen.
Product ID | 49288-0701_89f9e682-acd9-4cc7-982d-c32f69b33b07 |
NDC | 49288-0701 |
Product Type | Human Prescription Drug |
Proprietary Name | Treatment Set TS331955 |
Generic Name | Treatment Set Ts331955 |
Dosage Form | Injection, Solution |
Route of Administration | INTRADERMAL; SUBCUTANEOUS |
Marketing Start Date | 1986-10-31 |
Marketing Category | BLA / BLA |
Application Number | BLA102223 |
Labeler Name | Antigen Laboratories, Inc. |
Substance Name | POA PRATENSIS POLLEN; CYNODON DACTYLON POLLEN; SORGHUM HALEPENSE POLLEN |
Active Ingredient Strength | 27 [BAU]/mL; [BAU]/mL; g/mL |
Pharm Classes | Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Standardized Pollen Allergenic Extract [EPC],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS] |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 1986-10-31 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA102223 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1986-10-31 |
Inactivation Date | 2019-10-21 |
Ingredient | Strength |
---|---|
POA PRATENSIS POLLEN | 26.67 [BAU]/mL |